Careers

Director, Product Development
logoThe Pan-Provincial Vaccine Enterprise, Inc., (PREVENT) was established in March 2008 as a not-for-profit corporation with initial funding provided by the Government of Canada through the Centres of Excellence in Commercialization and Research Program of the National Centres of Excellence Office. Its head office is located at the University of Saskatchewan, Saskatoon, with nodes in Halifax and Vancouver. The mandate of PREVENT is to catalyze the commercialization of vaccines for diseases of significant public health importance by conducting R&D activities up to early stage clinical trials in collaboration with both public and private sector partners.

We are currently accepting applications for the following employment opportunity:

Director, Product Development

The Director of Product Development will be responsible for managing the development of specific vaccine projects carried out at institutions across the country. The incumbent will work with Project Managers to ensure that all projects meet timelines, are within the allocated budgets and that reporting is carried out on a timely fashion. With the other Directors, the Director of Product Development will also be involved in the communication of results to both public and private sector partners.

The successful candidate:
  • Will be responsible for assembling and directing multidisciplinary vaccine development teams.
  • Will supervise the activities of Project Managers at each site.
  • Will work with the CEO and the Director of Commercialization to ensure that external resources are obtained for manufacture and testing of vaccines and vaccine components

The Person

Qualifications: The Director of Product Development will have an advanced degree in the health sciences or a combination of a lesser degree plus equivalent experience.

Experience: The Director will have a minimum of five years of project management experience preferably within the vaccine area. The successful applicant will have a sound knowledge of the vaccine development pathways in Canada and internationally and will have effective management and interpersonal skills.

Job Requirements:
  • Strong leadership and team-building skills.
  • Ability to facilitate and manage multidisciplinary R & D teams.
  • Good oral and written communication and presentation skills.
  • Ability to work under pressure and to meet deadlines.
  • Excellent quantitative and qualitative assessment skills.
  • Knowledge of emerging technologies in the vaccine field.
  • Ability to translate strategic decisions into practice.
  • Must be able to travel to project sites where appropriate

You must be eligible to work in Canada. We thank all candidates for their interest, however, only those selected for an interview will be contacted.

Apply in strictest confidence by January 31, 2011.

Dr. Naveen Anand, Chief Executive Officer, PREVENT,
120 Veterinary Road, Saskatoon, Saskatchewan S7N 5E3
e-mail: Deprecated: Function split() is deprecated in /cwis/aliases/prevent-cecr/include/lib.inc on line 60 prevent.hr@usask.ca



Did you know?
image of Mycobacterium tuberculosis culture

This is a close-up of a Mycobacterium tuberculosis culture. Tuberculosis is a highly infectious and often attacks the lungs; if left untreated, the active disease has an extremely high (>50%) fatality rate. Screening programs and vaccination are the main methods of prevention.

Credit: Content provider CDC/Dr. George Kubica, PD-USGov-HHS-CDC.

Source: This media comes from the Centers for Disease Control and Prevention's Public Health Image Library (PHIL), part of the United States Department of Health and Human Services.

BACKGROUNDER

Immunization:
Inoculation and Vaccination

Inoculation (also known as variolation) was introduced to the west by Lady Mary Wortley Montagu (1689-1762), who witnessed inoculation being
portrait of lady
practiced by physicians in Constantinople,[12] and was greatly impressed:[13] she had lost a brother to smallpox and bore facial scars from the disease herself. In 1718 she had the embassy surgeon inoculate her son, and in 1721, after returning to England, had her daughter inoculated[14]. In 1722 the Prince of Wales' daughters received inoculations[16].

The practice of inoculation slowly spread amongst the royal families of Europe, followed by general adoption amongst the rest of the population. Given the severe consequences of smallpox in Europe in the 18th century, many parents felt that the benefits outweighed the risks and so inoculated their children.[21] [22]